Evidence map›Paper›PMID 40332720›Full record

ArticleScience and engineering ethics2025

Health Technologies and Impermissible Delays: The Case of Digital Breast Tomosynthesis.

Simon Rosenqvist, Magnus Dustler, Johan Brännmark

Abstract read
In one paragraph

Article in Science and engineering ethics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simon RosenqvistDepartment of Philosophy, Linguistics and Theory of Science, University of Gothenburg, Box 200, Göteborg, 405 30, Sweden. simon.rosenqvist@gu.se.ORCID 0000-0001-8017-0672
Magnus DustlerDiagnostic Radiology, Department of Translational Medicine, Lund University, Malmö, 205 02, Sweden.ORCID 0000-0002-5699-9664
Johan BrännmarkDepartment of Philosophy, Stockholm University, Universitetsvägen 10D, Stockholm, 106 91, Sweden.ORCID 0000-0001-6123-479X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper argues that we have a moral obligation to implement certain health technologies even if we have limited or incomplete evidence of their effectiveness. The focus is on technologies used in non-emergency settings, as opposed to "exceptional cases" such as compassionate use and emergency approvals during public health emergencies. A broadly plausible moral principle - the Ecumenical Principle - is introduced and applied to a test case: the use of Digital Breast Tomosynthesis in mammographic screening. The paper concludes by exploring the implications of the Ecumenical Principle for the adoption of other new health technologies.

Indexed as

Biomedical TechnologyBreast NeoplasmsEarly Detection of CancerMammographyMoralsFemaleHumansClinical utilityHealth technologiesHealth technology assessmentsMammographyMedical ethicsMoral principles

Identifiers

PMID40332720
PMCPMC12058816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.